Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Thrombosis Research
|
December 1, 1980
Sex differences in bleeding time and blood loss in normal subjects following aspirin ingestion
V P Young, A R Giles, J Pater, et al.
Blood
|
November 1, 1991
Alpha 2-macroglobulin binds and inhibits activated protein C
H Hoogendoorn, C H Toh, M E Nesheim, et al.
Blood
|
February 1, 1984
Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency)
A R Giles, S Tinlin, H Hoogendoorn, et al.
Blood
|
August 8, 1998
Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function
J A Samis, E Kam, M E Nesheim, et al.
British Journal of Haematology
|
November 1, 1988
Carrier detection strategy in haemophilia A: the benefits of combined DNA marker analysis and coagulation testing in sporadic haemophilic families
D Lillicrap, J J Holden, A R Giles, et al.
Thrombosis Research
|
February 1, 1980
The thrombogenicity of prothrombin complex concentrates: I. The relationship between in vitro characteristics and in vivo thrombogenicity in rabbits
A R Giles, M Johnston, H Hoogendoorn, et al.
The Journal of Clinical Investigation
|
July 1, 1988
Factor VIII-bypassing activity of bovine tissue factor using the canine hemophilic model
D P O'Brien, A R Giles, K M Tate, et al.
Archives of Pathology & Laboratory Medicine
|
June 1, 1987
Erythroblast multinuclearity in bone marrow and spleen. Congenital dyserythropoietic anemia-like abnormalities without functional evidence of dyserythropoiesis
D P Lillicrap, W E Corbett, A R Giles, et al.
American Journal of Hematology
|
November 1, 1987
Carrier detection in the hemophilias
D P Lillicrap, B N White, J J Holden, et al.
Thrombosis and Haemostasis
|
May 6, 1998
A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis
A R Giles, B Verbruggen, G E Rivard, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Thrombosis Research
|
December 1, 1980
Sex differences in bleeding time and blood loss in normal subjects following aspirin ingestion
V P Young, A R Giles, J Pater, et al.
Blood
|
November 1, 1991
Alpha 2-macroglobulin binds and inhibits activated protein C
H Hoogendoorn, C H Toh, M E Nesheim, et al.
Blood
|
February 1, 1984
Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency)
A R Giles, S Tinlin, H Hoogendoorn, et al.
Blood
|
August 8, 1998
Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function
J A Samis, E Kam, M E Nesheim, et al.
British Journal of Haematology
|
November 1, 1988
Carrier detection strategy in haemophilia A: the benefits of combined DNA marker analysis and coagulation testing in sporadic haemophilic families
D Lillicrap, J J Holden, A R Giles, et al.
Thrombosis Research
|
February 1, 1980
The thrombogenicity of prothrombin complex concentrates: I. The relationship between in vitro characteristics and in vivo thrombogenicity in rabbits
A R Giles, M Johnston, H Hoogendoorn, et al.
The Journal of Clinical Investigation
|
July 1, 1988
Factor VIII-bypassing activity of bovine tissue factor using the canine hemophilic model
D P O'Brien, A R Giles, K M Tate, et al.
Archives of Pathology & Laboratory Medicine
|
June 1, 1987
Erythroblast multinuclearity in bone marrow and spleen. Congenital dyserythropoietic anemia-like abnormalities without functional evidence of dyserythropoiesis
D P Lillicrap, W E Corbett, A R Giles, et al.
American Journal of Hematology
|
November 1, 1987
Carrier detection in the hemophilias
D P Lillicrap, B N White, J J Holden, et al.
Thrombosis and Haemostasis
|
May 6, 1998
A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis
A R Giles, B Verbruggen, G E Rivard, et al.
Page
of 8